Join experts Jonathan Mizrah, a medical oncologist at Ochsner Health specializing in HCC treatment, Lingling Du, who focuses on HCC trials, Adam Burgoyne from UCSD discussing immunotherapy communication, and interventional radiologist Zachary Berman on an insightful exploration of advanced liver cancer treatments. They discuss the promising role of combination therapies, particularly TACE with immunotherapy, and dive into groundbreaking clinical trial results. Simplifying complex mechanisms, they emphasize the importance of personalized treatment strategies and ongoing patient care.

In this engaging discussion, Dr. Steven Young, a hepatologist, shares his insights on HCC diagnosis and streamlined transplant evaluations. Dr. Jonathan Mizrahi, a medical oncologist, dives into systemic therapies for HCC and building essential referral networks. Patient navigator Deondra Bonds-Adams emphasizes the crucial role of patient education and care coordination. They explore multidisciplinary approaches that improve patient outcomes, tackle barriers in scheduling, and highlight the importance of communication and collaboration in hepatocellular carcinoma care.